PharmaDrug CEO says completion of cGMP substance manufacturing advances its programs
October 5, 2022
PharmaDrug says it aims to file provisional patent for treatment of…
August 26, 2022
PharmaDrug streamlines its focus on biotech following sale of German cannabis…
August 3, 2022
PharmaDrug CEO says cepharanthine study supports the move towards FDA clinical…
June 21, 2022
PharmaDrug Inc focused on biotech strategy as it sells German medical…
May 31, 2022
PharmaDrug advances its glaucoma research program with selection of lead DMT…
May 4, 2022
PharmaDrug files patent after positive findings for PD-001 and chemotherapy in…
April 20, 2022
PharmaDrug advances DMT-analogue glaucoma program with fabrication of medical device
April 11, 2022
Pharmadrug advances PD-001, its improved version of cepharanthine
April 5, 2022
Wall Street Reporter Interview with PharmaDrug CEO Daniel Cohen & CSO…
January 27, 2022
“World Needs More Antiviral Pills”| Daniel Cohen CEO Pharmadrug
January 25, 2022
PharmaDrug details upcoming program with Terasaki using DMT formulation to cure…
November 8, 2021
Pharmadrug preps for anticipated cannabis legalization in Germany by increasing product…
November 1, 2021
PharmaDrug reveals positive research results for cepharanthine in the treatment of…
October 19, 2021
PharmaDrug Inc granted pre-IND meeting request by FDA for oral antiviral…
September 28, 2021
PharmaDrug launches Slim MycoWeRx brand of functional mushrooms under Super Smart…
September 23, 2021
PharmaDrug CEO Daniel Cohen On Johns Hopkins University Partnership to Evaluate…
August 27, 2021
PharmaDrug’s JHU Partnership To Study DMT, Psychedelics, And The Future Of…
August 27, 2021
PharmaDrug forms clinical research collaboration with Johns Hopkins University
August 25, 2021
PharmaDrug teams up with Terasaki Institute to develop DMT delivery platform…
August 5, 2021
PharmaDrug’s study results show cepharanthine inhibits cancer cell growth in 20…
July 29, 2021
Daniel Cohen, Pharmadrug CEO, Weighs in With Updates on Cepharanthine
July 22, 2021
PharmaDrug reveals ‘significant’ results from preclinical cepharanthine study in cancer
July 14, 2021
Pharmadrug advancing development of cepharanthine to potentially treat coronavirus
June 23, 2021
CEO Daniel Cohen on COVID, Cancer, Cepharanthine, and More for PharmaDrug
June 23, 2021
PharmaDrug launches its online retail platform Slim Winkel in the Netherlands…
June 7, 2021
PharmaDrug ‘presses the go button’ on its Slim Winkel-branded online retail…
May 18, 2021